| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 4.37B | 4.71B | 4.40B | 7.63B | 8.44B | 6.82B |
| Gross Profit | 2.42B | 2.72B | 2.47B | 5.00B | 5.70B | 4.45B |
| EBITDA | 887.00M | 711.40M | 1.04B | 3.44B | 4.10B | 2.87B |
| Net Income | -96.60M | 202.20M | -500.00K | 1.91B | 2.24B | 1.29B |
Balance Sheet | ||||||
| Total Assets | 14.33B | 14.37B | 15.37B | 15.87B | 16.37B | 16.20B |
| Cash, Cash Equivalents and Short-Term Investments | 250.70M | 240.30M | 771.70M | 319.70M | 234.00M | 319.40M |
| Total Debt | 5.40B | 5.54B | 5.67B | 6.03B | 6.60B | 7.85B |
| Total Liabilities | 7.77B | 7.93B | 8.30B | 9.22B | 9.86B | 10.30B |
| Stockholders Equity | 6.56B | 6.43B | 7.08B | 6.66B | 6.51B | 5.89B |
Cash Flow | ||||||
| Free Cash Flow | 819.90M | 871.00M | 772.10M | 2.61B | 3.13B | 2.47B |
| Operating Cash Flow | 911.00M | 962.10M | 898.10M | 2.89B | 3.62B | 2.84B |
| Investing Cash Flow | -199.40M | -195.50M | -287.80M | -392.10M | -599.50M | -477.70M |
| Financing Cash Flow | -1.05B | -1.30B | -158.30M | -2.41B | -3.10B | -2.33B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
81 Outperform | $76.70B | 69.45 | 19.05% | 0.62% | 23.90% | -63.09% | |
77 Outperform | $75.58B | 10.55 | 26.14% | 1.79% | 2.37% | 13.28% | |
72 Outperform | $42.96B | -183.45 | 7.45% | ― | -9.04% | -4.21% | |
64 Neutral | $49.30B | 173.03 | 3.05% | 2.79% | 7.08% | ― | |
64 Neutral | $11.06B | 58.25 | 6.30% | 4.37% | 2.33% | -6.12% | |
62 Neutral | $57.07B | 215.94 | 0.86% | 1.28% | 0.79% | -86.68% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% |